New Weight-Loss Drug Burns Fat Without Suppressing Appetite

Scientists have developed a new weight-loss drug that works differently from existing analogs. This new approach allows for the elimination of fat deposits in a short period without the need to suppress appetite.

Mechanism of Action

The developed drug, conditionally named "Ozempic 2.0," is designed to directly burn fat cells. Unlike traditional remedies, it does not work by reducing appetite but instead acts directly on the tissue itself.

During clinical trials, the medication was injected directly into the abdominal area. This allowed for a localized effect, reducing the volume of both subcutaneous and visceral fat around internal organs specifically at the injection site.

Safety and Prospects

Researchers note the absence of serious side effects when using the product. The drug, code-named CBL-514, has already moved to the third phase of clinical trials, bringing its potential market launch closer.

The emergence of such a method could significantly change the approach to fighting excess weight, offering an alternative to strict diets and lengthy weight loss processes.